RecruitingPhase 4NCT06367855
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
Sponsor
Potsawat Surabotsopon
Enrollment
60 participants
Start Date
May 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.
Eligibility
Min Age: 50 YearsMax Age: 80 Years
Inclusion Criteria2
- Age range: 50-80 years old.
- Undergoing MIS TLIF surgery at 1-2 spinal levels.
Exclusion Criteria4
- Previously undergone spine surgery.
- HbA1C greater than or equal to 7.5 mg%
- Allergic to all types of experimental medication.
- History of using systemic steroids.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexamethasone
long-acting corticosteroid IV route
DRUGNormal saline
normal saline
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06367855
Related Trials
Organoid Models of Hepatocellular Carcinoma
NCT069298451 location
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
NCT062134541 location
Comparison of Cumulative Opioid Consumption Between Variable-Rate Feedback Infusion and Fixed-Rate Basal Infusion Modes of Intravenous PCA Following Mixed Surgery
NCT073618221 location
Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
NCT071820451 location
Regular Diet After Colorectal Surgery
NCT075408451 location